SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-043850
Filing Date
2012-08-09
Accepted
2012-08-09 09:37:12
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A v319901_10qa.htm 10-Q/A 23013
2 EXHIBIT 31.1 v319901_ex31-1.htm EX-31.1 8934
3 EXHIBIT 31.2 v319901_ex31-2.htm EX-31.2 8636
4 EXHIBIT 32.1 v319901_ex32-1.htm EX-32.1 4372
  Complete submission text file 0001144204-12-043850.txt   2446326

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20120630.xml EX-101.INS 349414
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20120630.xsd EX-101.SCH 32395
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20120630_cal.xml EX-101.CAL 38730
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20120630_def.xml EX-101.DEF 168979
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20120630_lab.xml EX-101.LAB 239584
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20120630_pre.xml EX-101.PRE 202420
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-10113 | Film No.: 121018761
SIC: 2834 Pharmaceutical Preparations